GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Precipio Inc (NAS:PRPO) » Definitions » Cyclically Adjusted PB Ratio

Precipio (Precipio) Cyclically Adjusted PB Ratio : 0.01 (As of May. 06, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Precipio Cyclically Adjusted PB Ratio?

As of today (2024-05-06), Precipio's current share price is $5.80. Precipio's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was $1,149.72. Precipio's Cyclically Adjusted PB Ratio for today is 0.01.

The historical rank and industry rank for Precipio's Cyclically Adjusted PB Ratio or its related term are showing as below:

PRPO' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.17   Max: 1.42
Current: 0.01

During the past years, Precipio's highest Cyclically Adjusted PB Ratio was 1.42. The lowest was 0.01. And the median was 0.17.

PRPO's Cyclically Adjusted PB Ratio is ranked better than
99.24% of 131 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.97 vs PRPO: 0.01

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Precipio's adjusted book value per share data for the three months ended in Dec. 2023 was $10.160. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1,149.72 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Precipio Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Precipio's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precipio Cyclically Adjusted PB Ratio Chart

Precipio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.01

Precipio Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.01

Competitive Comparison of Precipio's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, Precipio's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Precipio's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Precipio's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Precipio's Cyclically Adjusted PB Ratio falls into.



Precipio Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Precipio's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=5.80/1149.72
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Precipio's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Precipio's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=10.16/129.4194*129.4194
=10.160

Current CPI (Dec. 2023) = 129.4194.

Precipio Quarterly Data

Book Value per Share CPI Adj_Book
201403 17,380.488 99.695 22,562.652
201406 12,574.390 100.560 16,183.155
201409 12,430.488 100.428 16,018.934
201412 7,236.667 99.070 9,453.598
201503 7,579.545 99.621 9,846.711
201506 7,944.526 100.684 10,211.919
201509 4,307.742 100.392 5,553.313
201512 -8,296.774 99.792 -10,759.973
201603 -6,710.435 100.470 -8,643.944
201606 -6,339.300 101.688 -8,068.087
201609 -6,651.493 101.861 -8,451.048
201612 -2,200.000 101.863 -2,795.161
201703 -6,927.852 102.862 -8,716.501
201706 924.719 103.349 1,157.984
201709 648.015 104.136 805.351
201712 383.201 104.011 476.811
201803 204.515 105.290 251.385
201806 162.221 106.317 197.472
201809 115.924 106.507 140.863
201812 53.271 105.998 65.042
201903 45.682 107.251 55.125
201906 47.476 108.070 56.855
201909 42.864 108.329 51.209
201912 33.439 108.420 39.916
202003 23.742 108.902 28.215
202006 17.254 108.767 20.530
202009 16.591 109.815 19.553
202012 16.084 109.897 18.941
202103 16.027 111.754 18.560
202106 23.981 114.631 27.075
202109 22.794 115.734 25.489
202112 21.634 117.630 23.802
202203 19.557 121.301 20.866
202206 18.066 125.017 18.702
202209 15.947 125.227 16.481
202212 14.287 125.222 14.766
202303 12.121 127.348 12.318
202306 10.178 128.729 10.233
202309 9.371 129.860 9.339
202312 10.160 129.419 10.160

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Precipio  (NAS:PRPO) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Precipio Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Precipio's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Precipio (Precipio) Business Description

Traded in Other Exchanges
N/A
Address
4 Science Park, New Haven, CT, USA, 06511
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings.
Executives
Richard A Sandberg director 330 NEVEDA STREET, NEWTON MA 02460-1458
Ahmed Zaki Sabet officer: Chief Operations Officer 33 ANDYS DR, EAST HAVEN CT 06512
Ilan Danieli director, officer: Chief Executive Officer 14707 CALIFORNIA STREET, SUITE 5, OMAHA NE 68154
Matthew Gage officer: Chief Financial Officer 56 STAGECOACH CIRCLE, MILFORD CT 06460
David Seth Cohen director, 10 percent owner C/O STANDARD OIL, 299 BISHOP AVENUE, BRIDGEPORT CT 06610
Ronald Asbury Andrews director 5791 VAN ALLEN WAY, CARLSBAD CA 92008
Randal J Kirk 10 percent owner 1881 GROVE AVENUE, RADFORD VA 24141
Kathleen Laporte director
Robert Patzig director THE GOVERNOR TYLER, 1881 GROVE AVENUE, RADFORD VA 24141
Michael A Luther director 21 CORPORATE CIRCLE, ALBANY NY 12203
Jeffrey Cossman director C/O PRECIPIO INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Samuel D Riccitelli director 2850 FRONTIER DR., WARSAW IN 46582
Carl Iberger officer: Chief Financial Officer C/O PRECIPIO, INC., 12325 EMMET STREET, OMAHA NE 68164
Douglas Fisher director 587 PATROL RD, WOODSIDE CA 94062
Mark Rimer director, 10 percent owner C/O PRECIPIO, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511